TN2015000176A1 - Pastille medicamenteuse a base d'ibuprofene sodique dihydrate - Google Patents

Pastille medicamenteuse a base d'ibuprofene sodique dihydrate

Info

Publication number
TN2015000176A1
TN2015000176A1 TNP2015000176A TN2015000176A TN2015000176A1 TN 2015000176 A1 TN2015000176 A1 TN 2015000176A1 TN P2015000176 A TNP2015000176 A TN P2015000176A TN 2015000176 A TN2015000176 A TN 2015000176A TN 2015000176 A1 TN2015000176 A1 TN 2015000176A1
Authority
TN
Tunisia
Prior art keywords
drug
pastille
sodium dihydrate
ibuprofen sodium
dihydrate
Prior art date
Application number
TNP2015000176A
Other languages
English (en)
Inventor
Jean-François Cordoliani
Nadine Harambillet
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48050846&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TN2015000176(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of TN2015000176A1 publication Critical patent/TN2015000176A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention a pour objet des pastilles médicamenteuses à sucer, de consistance solide pour se dissoudre dans la cavité buccale comprenant au moins l'ibuprofène sodique dihydraté comme principe actif, destinées au traitement des affections bucco-pharyngées.
TNP2015000176A 2012-11-14 2015-05-07 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate TN2015000176A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1260815A FR2997856B1 (fr) 2012-11-14 2012-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
PCT/EP2013/073868 WO2014076203A1 (fr) 2012-11-14 2013-11-14 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate

Publications (1)

Publication Number Publication Date
TN2015000176A1 true TN2015000176A1 (fr) 2016-10-03

Family

ID=48050846

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2015000176A TN2015000176A1 (fr) 2012-11-14 2015-05-07 Pastille medicamenteuse a base d'ibuprofene sodique dihydrate

Country Status (17)

Country Link
US (1) US20160287514A1 (fr)
EP (1) EP2919752A1 (fr)
JP (1) JP6258342B2 (fr)
KR (1) KR20150084919A (fr)
CN (1) CN104780907A (fr)
AP (1) AP2015008515A0 (fr)
AU (1) AU2013346775B2 (fr)
BR (1) BR112015010808A2 (fr)
CA (1) CA2890832A1 (fr)
CL (1) CL2015001308A1 (fr)
FR (1) FR2997856B1 (fr)
MA (1) MA38162B1 (fr)
MX (1) MX2015006011A (fr)
RU (1) RU2015122217A (fr)
TN (1) TN2015000176A1 (fr)
WO (1) WO2014076203A1 (fr)
ZA (1) ZA201504280B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7214331B2 (ja) * 2016-12-28 2023-01-30 小林製薬株式会社 医薬組成物
WO2019104050A1 (fr) * 2017-11-27 2019-05-31 Lodaat Pharmaceuticals Procédés de préparation de compositions curcuminoïdes
KR20220050932A (ko) * 2019-08-22 2022-04-25 어플라이드 바이올로지컬 래버러토리즈 인코포레이티드 비-스테로이드성 항-염증 약물을 사용한 조성물 및 방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2145219C1 (ru) * 1991-05-13 2000-02-10 Дзе Бутс Компани ПЛС Фармацевтическая композиция, содержащая s(-)-2-(4-изобутилфенил)пропионат натрия, способ получения натриевой соли энантиомера 2-(4-изобутилфенил)пропионовой кислоты, s(-)-2-(4-изобутилфенил)пропионат натрия дигидрат
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
AU2004320488A1 (en) * 2004-06-07 2005-12-22 Strides Arcolab Limited Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
AU2005271036B2 (en) * 2004-08-12 2009-11-19 Reckitt Benckiser Healthcare (Uk) Limited Granules comprising paracetamol a NSAID and a sugar alcohol made by melt extrusion
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
WO2007055887A1 (fr) * 2005-11-02 2007-05-18 Teikoku Pharma Usa, Inc. Formulations de doses orales d'ibuprofene organoleptiquement acceptables, procedes de preparation et d'utilisation de celles-ci
JP2009538359A (ja) * 2006-05-26 2009-11-05 オースペックス・ファーマシューティカルズ・インコーポレイテッド 置換カルボン酸化合物の製造および利用
CN102557918B (zh) * 2011-11-28 2013-08-21 海南永田药物研究院有限公司 一种布洛芬钠化合物及其制法

Also Published As

Publication number Publication date
EP2919752A1 (fr) 2015-09-23
US20160287514A1 (en) 2016-10-06
AP2015008515A0 (en) 2015-06-30
CA2890832A1 (fr) 2014-05-22
WO2014076203A1 (fr) 2014-05-22
MA38162A1 (fr) 2016-12-30
BR112015010808A2 (pt) 2017-07-11
JP2015537019A (ja) 2015-12-24
ZA201504280B (en) 2017-09-27
AU2013346775B2 (en) 2018-06-28
JP6258342B2 (ja) 2018-01-10
CN104780907A (zh) 2015-07-15
CL2015001308A1 (es) 2015-08-28
RU2015122217A (ru) 2017-01-10
MX2015006011A (es) 2015-09-10
KR20150084919A (ko) 2015-07-22
FR2997856B1 (fr) 2015-04-24
MA38162B1 (fr) 2019-12-31
FR2997856A1 (fr) 2014-05-16
AU2013346775A1 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
CY1123549T1 (el) Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης
MA33939B1 (fr) 5-alcynyl-pyrimidines
EA201071144A1 (ru) Гетероциклические производные
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
EA201201665A1 (ru) Новые соединения
TR201903492T4 (tr) Apomorfin ve organik asitler içeren bileşimler ve bunların kullanım alanları.
EA201270216A1 (ru) Фармацевтический состав
EA201070421A1 (ru) Микрорибонуклеиновые кислоты
MX2013001204A (es) Compuesto para el tratamiento/prevencion de enfermedades inflamatorias oculares.
MX2011007192A (es) Composicion farmaceutica.
MA38349A1 (fr) Œstra-1,3,5(10),16-tétraéno-3-carboxamide pour inhiber la 17-bêta-hydroxystéroïde déshydrogénase (akr1c3)
FR2915683B1 (fr) Formulations pharmaceutiques auto-precipitantes pour la liberation modifiee de principe actif
EA201690854A1 (ru) Фармацевтические композиции с гидратирующим и смазывающим действием
DOP2011000335A (es) Combinacion antitumoral que comprende ave8062 y sorafenib
TN2015000176A1 (fr) Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
EA201690005A1 (ru) Состав с модифицированной кинетикой высвобождения
EA201500245A1 (ru) Твердый фармацевтический препарат, который содержит левотироксин
MA34946B1 (fr) Nouvelles benzodioxolepipérazines
MA35457B1 (fr) Nouvelles formulations de pyriméthanil et leur utilisations dans le traitement des cultures
EA201490573A1 (ru) Соединение бензотиазолона
ECSP15030460A (es) Composición de difenidol de liberación prolongada
EA201270653A1 (ru) Антагонист dpи его применение
EA201100287A1 (ru) Композиция ропинирола
AR077915A1 (es) Forma cristalina de pemirolast
CR20110674A (es) Otamixaban para el tratamiento de pacientes con alteración renal y de edad avanzada con infarto de miocardio sin elevación del ST